Using a transgenic mouse model we show that increased intrathymic expression of interleukin 4 (IL4) significantly perturbs the development of thymocytes. Transgenic double-positive (CD4+CD8+) thymocytes, which are present in dramatically reduced numbers, exhibit increased T cell receptor (TCR) expression and increased mobilization ofcalcium mediated by these receptors. In contrast, transgenic single-positive (CD4+CD8 -and CD4 -CD8+) thymocytes and peripheral T cells exhibit decreased TCRmediated calcium mobilization. The development of CD4 -CD8+ thymocytes is significantly perturbed by 114 expressed in vivo; only peripheral CD4+ T cells are found in significant numbers in transgenic mice, while CD4 -CD8+ thymocytes are present in increased numbers, apparently because of their failure to emigrate to the periphery. In contrast to these selective effects on T cell development, no significant differences in the numbers ofB cells or mast cells, or in the plasma levels of IgE and IgG1 are observed between transgenic and control mice. These observations suggest that 114 in vivo exerts its major effects locally rather than systemically, even when its expression is constitutively increased.
Summary
Using a transgenic mouse model we show that increased intrathymic expression of interleukin 4 (IL4) significantly perturbs the development of thymocytes. Transgenic double-positive (CD4+CD8+) thymocytes, which are present in dramatically reduced numbers, exhibit increased T cell receptor (TCR) expression and increased mobilization ofcalcium mediated by these receptors. In contrast, transgenic single-positive (CD4+CD8 -and CD4 -CD8+) thymocytes and peripheral T cells exhibit decreased TCRmediated calcium mobilization. The development of CD4 -CD8+ thymocytes is significantly perturbed by 114 expressed in vivo; only peripheral CD4+ T cells are found in significant numbers in transgenic mice, while CD4 -CD8+ thymocytes are present in increased numbers, apparently because of their failure to emigrate to the periphery. In contrast to these selective effects on T cell development, no significant differences in the numbers ofB cells or mast cells, or in the plasma levels of IgE and IgG1 are observed between transgenic and control mice. These observations suggest that 114 in vivo exerts its major effects locally rather than systemically, even when its expression is constitutively increased. I 1,4 is a cytokine secreted by T cells and mast cells which has pleotropic effects on a wide variety of hematopoietic cell types in vitro (1) . Originally described as a growth factor for partially activated B cells (2) , IIr4 has subsequently been shown to promote T cell and mast cell growth as well (3) (4) (5) , and to have multiple effects on the differentiation of mature lymphocytes (1, (6) (7) (8) (9) (10) . These 11,4-mediated effects include increased class II MHC surface expression and IgG1 and IgE production by B cells (6) (7) (8) , enhanced generation of T cellmediated cytotoxicity (9) , and the induction of surface CD8 expression by CD4+ T cell clones (10) . Although these findings suggest that HA regulates multiple aspects of antigenspecific immunity, the production of IgE by B-lineage cells is the only lymphocyte-mediated function which has clearly been shown to depend on the production of IL-4 in vivo (11, 12) .
The expression ofIL4 mRNA by thymocytes in vivo during fetal ontogeny (13) , and the secretion of 11,4 by fetal and adult CD4 -CD8 -(double-negative) thymocytes after in vitro activation (14, 15) , suggest that this cytokine may also have a role in normal T cell development . A number of in vitro studies have documented that IL4 can either augment or inhibit the growth of isolated thymocytes, depending on the cell population studied, the stimulus used for cell activation, and which other cytokines are present (15) (16) (17) (18) (19) (20) . Studies of CD4 -CD8' thymocyte differentiation in vitro indicate that 11,4 may favor the development of double-negative or CD8+ cells bearing .y/S rather than a/(3 T cell receptors (16, 21) . However, these studies do not satisfactorily address the function of IL4 in an intact intrathymic context ; it is likely that 114 and other cytokines significantly influence other components of the thymic microenvironment which provide essential signals regulating thymocyte growth, differentiation, and selection . Therefore, we have generated transgenic mice in which 11,4 is selectively expressed intrathymically. Such animals exhibit profound but selective disturbances in thymocyte development, including an accumulation of thymocytes bearing high levels of TCR-oi//3 and a CD4 -CD8+ surface phenotype. Remarkably, intrathymic 11.4 expression does not alter the normal pattern of Ig isotypes in plasma or B cell or mast cell abundance . These results suggest that 11,4 can behave as a natural regulator of thymocyte maturation, but that its effects are exerted locally rather than systemically. 0.7-kb BamH1 fragment (22), into the calf intestinal phosphatasetreated BarnHI site of an expression vector, p1017 (Chaffin, K. E., C. R. Beals, T M. Wilkie, K. A. Forbush, M. I. Simon, and R. M. Perlmutter, manuscript submitted for publication) using standard techniques (23) . In the final construct, the murine IL-4 cDNA segment was located 3' to a 3.2-kb murine proximal lck promoter segment at +37 with respect to the transcription start site (24, 25), and 5' to a 2.1-kb BamH1-EcoRI fragment of the human growth hormone (hGH)' gene (26) . The IL-4 cDNA was the generous gift of Dr. E. Severinson (University of Stockholm, Stockholm, Sweden).
Generation ofIck-IL4 Transgenic Mice. A 6.0-kb Nod fragment containing the lck-IL4 construct was purified by agarose gel electrophoresis onto DEAE-nitrocellulose paper (23) and diluted to 2 ng/ml in 10 mM Tris, 0.1 mM EDTA, pH 7.5 . Aliquots of this preparation were injected into the pronuclei of C57BL/6J X DBA/2J FZ hybrid mouse zygotes using standard techniques (27) . Viable zygotes were then transferred into the oviducts of recipient pseudopregnant females. Mice bearing the construct were detected by hybridization of blotted tail DNA as previously described (25), using a 32 P-labeled 0.6-kb Smal-EcoRI hGH fragment (26) as a probe. Tansgene-positive lines were propagated by backcrossing founder animals with C57BL/6J mice . In all experiments, nontransgenic littermates served as age-matched, wild-type controls . Original strains of C57BL/6J and DBA/2J mice were obtained from The Jackson Laboratories (Bar Harbor, ME) .
RNA Blots. Total RNA was isolated from tissue or cell preparations by the guanidinium-isothiocyanate/CsCl method (28) . RNA was quantitated spectrophotometrically, electrophoresed in 1% agarose gels made in 2.2 M formaldehyde, and blotted as previously described (29) . Hybridization and washing conditions were those previously described for 12 p-labeled DNA probes (30) . The murine 11,4 probe, which consisted of a 0.6-kb BamHI-SspI cDNA fragment (22), was "P-labeled using the random hexamer priming method (31) .
Cell Isolation and Stimulation. Single-cell suspensions of thymocytes and LN cells were prepared by finely mincing or teasing these tissues . To isolate spleen mononuclear cells, tissue was first disrupted with a fine-meshed sieve, and the mononuclear cell fraction was subsequently purified by Ficoll-Hypaque density gradient centrifugation (32) . Bone marrow cells were collected by irrigation of femurs andhumeri from euthanized mice (33) . As necessary, contaminating red cells were removed by hypotonic NH4Cl treatment (33) .
11,4 Assay. Thymocytes, splenocytes, or bone marrow cells (5 x 10 6/ml) from transgenic mice or control littermates were cultured in CT4S medium (34) (RPMI 1640 [Mediatech, Washington, DC] with 10% FCS [Hyclone Laboratories, Logan, UT]), .1 mM Na pyruvate, 2 MM L-glutamine, 0.05 mM 2-ME, 100 U/ml penicillin, and 100 pg/ml streptomycin for 24 h at 37°C in a humidified 5% COZ atmosphere . IL4 activity was determined by the ability of supernatants from these cell cultures to support the incorporation of [3H]thymidine by CT 4S cells (the kind gift of W E. Paul, National Institutes of Health [NIH], Bethesda, MD), exactly as described (34) . The concentration of IL4 in samples was interpolated from a standard curve generated using purified recombinant murine IL4. Based on this standard curve, the lower limit of detectability for IL4 in the CT4S assay was 10 pg/ml. An aliquot of each sample was preincubated with saturating concentrations (75 Wg/ml) of purified 111111 (anti-murine IL4) mAb (35) (NIH) . The remaining mAbs were purchased from Becton Dickinson (Mountain View, CA). Single or two-color staining of cells was performed at 4'C in PBS/1% BSA/0.1% Na azide (staining buffer) with saturating concentrations of mAb as previously described (41) . PEconjugated streptavidin (Biomeda, Foster City, CA) was used for detection of biotinylated mAb. For single or two-color analysis, at least 3 x 10 3 lymphocytes per sample were analyzed using an Epics C instrument (Coulter Electronics Inc., Hialeah, FL) equipped with an argon laser. For three-color staining of CD3, CD4, and CD8, cells in staining buffer were sequentially incubated for 15 min at 4°C with 500A .2 hybridoma supernatant, FITC-conjugated goat anti-hamster IgG (mouse and rat IgG absorbed) (Caltag Laboratories, South San Francisco, CA), 10% normal rat serum, biotinylated 53-6 .7, streptavidin-allophycocyanin (Biomeda), and PE-conjugated GK1.5 . Cells were extensively washed between each step. Three-color analysis was performed on an Epics 753 instrument (Coulter Electronics Inc.) using argon and helium-neon lasers. At least 1 x 104 list mode-gated events were collected per sample. Data was analyzed using MDADS and REPROMAN software (Fred Hutchinson Cancer Research Center, Seattle, WA) .
In Vivo Treatment with Anti-IL4 mAh Starting at 1 mo of age, transgenic mice or littermate controls were given three weekly injections by tail vein of either 10 mg of purified anti-111,4 111311 mAb (35) in 0.25-0.5 ml of PBS (pH 7.4) or PBS alone. Mice were sacrificed for analysis 1 wk after their final injection.
Ca z' Analysis. Cells (101/ml in RPMI medium with 10% FCS) were loaded with 3 pg/ml of the acetoxymethyl ester of indo-1 (42) for 45 min at 37°C in darkness, washed, and then stained with saturating concentration of azide-free PE-conjugated CD4 and FITC-conjugated CD8 mAb (Becton Dickinson) . After additional washing, cells were resuspended at 5 x 106/ml in RPMI medium . Cytoplasmic free (intracellular) calcium concentration ([Ca"] i) was measured in individual cells by cytofluorometrically determining their ratio of violet to blue emissions as previously described (43) ; PE and FITC fluorescence were also simultaneously determined . Measurements were performed at 37°C at a rate of -1,000 cells/s using a Cytofluorograph 50H with a model 2150 computer (Ortho Diagnostic Systems, Westwood, MA) as previously described (43, 44) . When baseline [Ca2'] ; was established after 2 min of cell flow, azide-free purified anti-CD3 mAb, 145-2C11 (37), or Con A (Pharmacia Fine Chemicals, Piscataway, NJ) were added to cells to final concentrations of 10 or 25 ug/ml, respectively, and flow was resumed. Computer analysis for [Ca'*Ii vs. time and percent-responding cells vs . time was performed as previously described (44) using the software Multitime (Phoenix Flow Systems, San Diego, CA).
T Cell Activation. Round-bottom 96-well microtiter plates (Corning Glass Works, Corning, NY) were incubated with either mAb 145-2C11(37) (10 jig/ml in PBS), mAb H57-597 (38) (1:10,000 dilution (vol/vol) of ascites in PBS, provided by Dr. J. Ledbetter (Oncogene, Seattle, WA), or with PBS alone for 2 h at 37°C and then washed five times with PBS. Spleen mononuclear cells (4 x 10°-2 x 10s) were added to wells in 0 .2 ml of CT 4S medium and incubated for 72 h at 37°C in a humidified atmosphere with 5% C02 . All wells were pulsed for the last 12 h of incubation with 1 FcCi of [3H]thymidine . Cells were harvested onto glass fiber filters and assayed for [3H)thymidine incorporation by liquid scintillation counting . All assays were performed in triplicate .
Ig Isotype Analysis. Ig levels were determined by an isotypespecific sandwich ELISA technique. The assays for IgGI, IgG3, and IgE levels were performed as previously described (45) . IgG2a, IgG2b, IgA, and IgM levels were similarly determined using appropriate isotype-specific goat anti-mouse antibodies (Southern Biotechnology Associates, Birmingham, AL) as first-step reagents to coat the wells of microtiter plates. After blocking with 5% nonfat dry milk, wells were incubated with plasma or isotype standards (Southern Biotechnology Associates) diluted in PBS/3% BSA for 1 h, washed six times with PBS/0 .5% Tween (Sigma Chemical Co., St. Louis, MO), and then incubated with appropriate isotypespecific, horseradish peroxidase-conjugated, goat anti-mouse antibodies (Southern Biotechnology Associates) for 1 h . After six washes with PBS/0.5% Tween, peroxidase-conjugated antibody was detected using TMB Microwell peroxidase substrate (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD) as specified by the manufacturer. Plates were read on an ELISA reader (Dynatech Laboratories, Inc., Alexandria, VA) . Data analysis of test samples was performed as previously described (45) .
Results
Selective Intrathymic Expression of11,4 in Ick-IL4 Transgenic Mice. To gain insight into the potential role of IL4 in T-lineage cell development in vivo, transgenic mice were generated in which increased 11,4 expression was selectively targeted to the thymus . Fig . 1 details the transgene expression construct (Ick-IL4) in which a 3.2-kb Ick proximal promoter segment (24, 25) was placed immediately 5' to a full-length murine IL4 cDNA clone. The Ick proximal promoter has previously been shown to direct the expression of other transgenes in a thymocyte-specific manner (reference 25 and Perlmutter, R. M ., unpublished results) . The IL4 cDNA segment was embedded within the hGH gene since intronic sequences appear to augment transgene expression (46) . By positioning the cDNA 5' to the translation initiation codon of the hGH gene, no growth hormone expression is observed (data not shown) .
Three transgene-positive mice that expressed detectable transgene-derived mRNA were obtained after injection of the kk-IL4 construct . These founder animals, designated 1315, 4453, and 4475 displayed a distinct perturbation of T-lineage cell development that included (a) thymic hypoplasia ; (b) a marked decrease in the number of CD4+CD8+ thymocytes ; (Fig. 2) . Transgene-encoded 114 transcripts, which contain 3' hGH sequences (Fig. 1) , were significantly larger and readily distinguished from the endogenous 0.7-kb IL4 transcripts found in EL-4 cells. Two major sizes of transgenic IL4 mRNA were observed, presumably because of alternative splicing of hGH intron sequences. Low levels of transgene transcripts were detected in spleen (ti1-2% of that found in thymocytes based on scanning densitometry) as well as LN tissue (data not shown), but not in nonlymphoid tissues . Endogenous RA transcripts were undetectable in RNA from all freshly isolated tissues of transgenic as well as littermate control mice (Fig. 2, data not shown) . Taken together, these results demonstrated that kk-IL4 mice had increased expression of IL4 mRNA which was largely confined to the thymus .
The CT4S cell proliferation assay (34) was used to measure the amount of biologically active IL4 secreted by transgenic or control cells after short-term in .vitro culture. In- The absolute number of cells ( x 106) for each surface phenotype is indicated in parentheses .
creased expression of 1174 mRNA by thymic tissue in kk-IL4 mice was paralleled by ILA secretion by thymocytes beginning as early as day 18 of fetal life (Table 1) . Anti-IL4 mAb completely neutralized this proliferative activity in the CTAS assay, confirming that it was attributable to IL-4. The amount of IL4 secretedby unstimulated thymocytes over a 24-h period ranged from -25 to 70 pg/ml based on the activity of purified rIL4 in the CT 4S assay. In contrast, IL4 was not detected in cultures of control thymocytes, or in cultures of splenocytes or bone marrow cells from either transgenic or control mice.
Perturbation of Thymocyte Development . The amount of thymic tissue in Ick-IL4 mice was markedly reduced compared with controls, with the loss of a clearly defined cortical region ( Table 2 , Fig. 3 A and B) . In virtually the entire organ, thymocytes were found in a loosely packed pattern characteristic of the normal medulla ( Fig. 3 C and D) . This reduction in thymocyte number compared with controls was evident as early as day 3 after birth but not at day 16 .5 of fetal gestation (data not shown) . Consistent with these findings, the proportion and absolute number of CD4 CD8' cells, a population which normally includes >75% of thymocytes and is found mainly in the cortex (47), were both markedly lower in transgenic compared with control mice (Fig . 4 A, Table 2 ) . This decrease was accompanied by an increased proportion of CD4 -CD8 -, CD4+CD8 -, and, particularly, CD4 -CD8' thymocytes . The CD4 -CD8+/ CD4+CD8 -thymocyte ratio in kk-IL4 mice was typically greater than 1 :1, and the absolute numbers of CD4 -CD8' cells exceeded those found in controls (Table 2) . A significant proportion of CD4+CD8 -and CD4 -CD8+ Ick-IL4 thymocytes were also noted to have moderately reduced surface expression of CD4 or CD8, respectively, compared with thymocytes from controls (Fig. 4 A) An increased proportion of lck-11,4 thymocytes expressed surface TCR-ci//3 as assessed by two-color staining with CD3 and pan-ci//3 TCR mAbs (Fig. 4 B) , while the small numbers (<5%) of thymocytes bearing TCR-,y/S did not differ significantly from that found in littermate controls (data not shown) . To further characterize the lck-IL4 thymocyte populations that expressed surface TCR, three color staining for CD3, CD4, and CD8 was performed . This revealed that most CD4 -CD8+ lck-IL4 thymocytes expressed detectable surface TCR, although a significant proportion of this population had lower amounts of surface TCR compared with control CD4 -CD8+ thymocytes (Fig. 4 C, left) . Thymocytes with this CD3+CD4 -CD8+ surface phenotype normally first appear at the very end of fetal ontogeny (day 19) and include CD4 -CD8+ cells destined to emigrate from the thymus (47) . In contrast, there was no significant increase in the number-of CD3 -CD4 -CD8+ thymocytes, a population which occurs earlier in fetal ontogeny (day 15), and is apparently the direct precursor of CD3 -CD4+CD8+ thymocytes (48, 49) . CD4+CD8 -thymocytes from transgenic and control mice exhibited similar levels of CD3 expression (data not shown) . However, the proportion of CD4+CD8+ thymocytes that were CD3`was strikingly increased in lck-IL 4 mice compared with controls (Fig. 4 C, 
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left and right) . In agreement with previous work (36), the amount of CD3 staining on CD3+CD4+CD8+ thymocytes from either transgenic or control animals was relatively low compared with that found on most single-positive cells.
Reversal of Thymic Abnormalities in lck-IL4 Mice Treated with
Anti-IL4 Antibody. To confirm that IL4 secretion was responsible for the phenotypic abnormalities of T-lineage cells in lck-IL4 mice, transgenic or control mice were treated for 1 mo with injections of either anti-IL4 mAb (111311) or PBS . Transgenic mice that received anti-11,4 mAb had striking increases in thymocyte number (Table 2) as well as partial normalization of thymic architecture (data not shown) . The composition of thymocyte subsets defined by surface expression of CD4, CD8, and CD3 was also modified towards that found in normal mice, after treatment with anti-IL4 but not PBS (Fig. 4 C, Table 2 ) . There were no discernible effects on the thymi of control mice as a result of treatment with either anti-IL-4 or PBS. These results showed that the perturbation of thymic development observed in lck-IL4 mice was critically dependent on the secretion of IL4 . Peripheral T Cells in lck-IL4 Mice. Phenotypic alterations in the peripheral T cell compartment were also evident in lck-IL4 mice . Most striking was the virtually complete absence of CD8+ T cells in the LN (Fig. 5 A) , spleen, and peripheral blood (data not shown) . CD4+ T cells were present at all of these sites, although in significantly reduced numbers (Fig. 5, A and B) . Unlike CD4+CD8 -thymocytes, the Ick-IL 4 peripheral CD4+ T cell population had surface levels of CD4 comparable with T cells from controls ( Fig . 5 B) . CD4+ T cells in Ick-IL4 mice also displayed normal levels of TCR (Fig. 5 B) as well as CD5, CD45, and Thy-1 (data not shown) . analogous patterns of CD4 and CD8 surface expression were directly compared. As shown in Fig. 6 , the calcium responses of transgenic thymocyte populations after stimulation were distinct from those observed in control cells: transgenic CD4+CD8* thymocytes had strikingly greater increases in mean [Ca 211, compared with control CD4+CD8+ thymocytes after treatment with anti-CD3 mAb (A), as well as Con A or antiTCR-oi//3 mAb (data not shown) . In contrast, the calcium response of single-positive thymocytes to anti-CD3 mAb treatment was dramatically lower than that of control populations (B and C) . CD4 -CD8 -transgenic and control thymocytes both had low levels of response under these conditions (data not shown) . When splenic CD4+ T cell populations were similarly analyzed, dramatically lower calcium responses were observed in transgenic cells compared with control cells after either anti-CD3 mAb or Con A treatment (D) . Similar results were obtained using LN CD4+ T cells (data not shown) . For all cell populations analyzed, the maximum percent of cells which gave a significant calcium response paralleled the peak mean [Caz+]i achieved by these cells (see legend to Fig. 6 ) . Transgenic peripheral CD8+ T splenic T cells from Ick-IL4 mice appeared to proliferate normally after cross-linking of their TCR-CD3 complexes with either anti-CD3 or anti-pan-ot/a TCR mAb (Fig. 7) . In addition to their apparently normal proliferative response, Ick-11A splenic T cells activated by anti-CD3 mAb also accumulated amounts of IL-2 mRNA which were similar to those in littermate control spleen T cells (data not shown) .
Additional Abnormalities in Ick-IIr4 Mice. LA-IL-4 mice were remarkably susceptible to parasitic infection. Conventionally housed transgenic mice, but not controls, invariably developed severe intestinal infection with the pinworm Syphacia obvelata (50) . Megacolon, rectal prolapse, and cecal perforation were frequent findings. Most severely infected mice died between 6 and 12 wk of age. In contrast, infection of conventionally housed Ick-1114 mice with mouse hepatitis virus only rarely caused significant disease . Since IL4 has been shown to increase IgE and IgG1 isotype production by activated B cells in vitro (8) , and to be directly involved in promoting IgE production in vivo during parasitic infection (11, 12) , we determined the concentrations of these and, for comparison, other Ig isotypes in the circulation of pinworm-infected Ick-IL4 mice and littermate controls (Table 3 ) . There were no significant differences between transgenic and control mice in their plasma levels of IgM, IgA, IgE, IgG1, IgG2b, or IgG3. An unexpected finding was that IgG2a levels were significantly higher in infected Ick-IL 4 mice compared with controls. This observation may reflect the higher antigenic load experienced by Ick-IL4 mice. These results, which suggested that B cell function was not grossly perturbed by the IL4 transgene, were consistent with the normal histologic appearance of lymphoid follicles and the normal numbers of peripheral B220+ B cells found in Ick-IL4 mice (data not shown) . Since IL4 has also been shown to act as a growth factor for mast cells (5), we histologically examined these transgenic mice for increased mast cell numbers using a Giemsa stain . However, we failed to find significant increases in mast cell abundance in any organs of kk-11A mice, including the skin (data not shown) . Discussion 114 has previously been shown to promote the growth of isolated thymorytes including fetal and adult CD4 -CD8 -cells, adult CD4+CD8 -and CD4 -CD8+ cells, but not CD4+CD8 + cells (15-21) . In vitro studies using murine CD4 -CD8 -or human CD4 -CD8 -CD3 -CD1 -thymocytes suggest that IL4 preferentially promotes differentiation of double-negative or CD8+ y/b Tlineage cells (16, 21) . Consistent with this interpretation, incubation of isolated double-positive or single-positive TCR ci/S+ thymorytes with 114 does not significantly alter their surface expression of CD4, CD8, or CD3 (Lewis, D., unpublished observations). These results contrast with those obtained in our in vivo model, which demonstrate a profound influence of IL4 on the abundance, surface phenotype, and TCRmediated activation of thymocytes, particularly TCR u/Q+ cells at later stages of maturation, and on the ability of mature thymorytes to successfully colonize the periphery. We conclude that proper interactions between cytokines and the thymic microenvironment are crucially important in regulating multiple aspects of T cell development .
11,4 expression by normal murine fetal thymorytes is highest at day 15 ofgestation, when the predominant thymocyte population is CD4 -CD8 -, but rapidly declines by day 16, becoming undetectable from day 18 of gestation onward (13) . This suggests a potential physiologic role for IL-4 in early thymic development . In preliminary experiments, we have examined the effects ofthe Ick-IL4 transgene on fetal thymic ontogeny at day 16 .5-17 of gestation and have found no significant differences between transgenic and control thymocytes with respect to CD3, CD4, or CD8 surface expression (data not shown) . Further, no significant differences were observed in the percentage of thymorytes bearing TCR--y/S, or in their surface expression of Thy-1, CD5, or CD45. IL4 secretion by Ick-11,4 but not control thymorytes is detectable as early as day 18 of gestation (Table 1) , and it is likely, based on the normal ontogeny of expression of the endogenous proximal Ick promoter, that thymocytes express the lck-IL4 transgene beginning as early as day 14 of gestation (reference 51; Lewis, D., and R. Perlmutter, unpublished observations) . These findings argue that increased intrathymic expression of 11,4 has little discernible impact on T cell development before the appearance of double-positive thymocytes . In contrast, the development of double-positive and TCRu/a-bearing single-positive thymocytes is dramatically affected by in situ IL4 production in adult mice. These results suggest that the progressive decrease in IL4 expression by thymorytes which occurs during late fetal ontogeny may be critical for subsequent normal T cell development . 9 6 Interleukin 4 In Situ Alters Thymocyte Development
The thymi ofkk-IL4 mice lacked a clearly defined cortex, a region which in normal mice predominantly contains doublepositive thymocytes (47) . Cortical CD4+CD8+ thymocyte depletion is also a prominent feature of thymi from mice that have been physiologically stressed or treated with glucocorticoids. However, under these conditions the CD4+CD8 -/ CD4 -CD8+ single-positive thymocyte ratio, which normally is -2-3:1, remains unchanged (52, 53) . In contrast, in kk-IL4 mice this ratio was typically 1:1 or less, reflecting an absolute increase in the number of CD4 -CD8+ thymocytes. Hence, the alterations observed in thymic development in kk-IL4 mice, which clearly depended on the secretion of IL4 (Table 2, Exp. 2; Fig. 4 C) , are unlikely to be simply the result of systemic stress.
The finding that CD4+CD8+ thymocytes had increased TCR surface expression in kk-11A mice is particularly noteworthy, since no cytokine has previously been shown to mediate this effect . Although the mechanism by which 11,4 increases surface TCR expression on double-positive cells remains to be determined, the results of treatment of lck-IL4 mice with anti-IL4 mAb clearly show that this effect is dependent on the actual secretion of 114. Similar increases in surface TCR expression by double-positive thymocytes have also been observed after in vivo treatment of normal mice with anti-CD4 but not anti-CD8 mAb (54, 55) , or when normal thymorytes are incubated in vitro in suspension but not as tissue fragments (55, 56) . In both cases, a posttranslational mechanism, in which assembled CD3-TCR complexes are more efficiently transported from the endoplasmic reticulum to the cell surface, appears to be involved (55) . These findings have led to the proposal that the thymic microenvironment may provide a signal through the CD4 molecule of CD4+CD8+ thymorytes which attenuates the surface expression of TCR by these cells (55) . We have found that the inclusion of IL4 in suspension cultures of normal thymocytes does not further augment surface TCR expression by double-positive thymocytes (Lewis, D., unpublished observations), suggesting that, like anti-CD4 mAb treatment, an intact thymic microenvironment is required for this 11,4-mediated effect. It remains to be determined whether an altered CD4-mediated signal in Ick-IL4 double-positive thymocytes is also responsible for their increased TCR expression, or whether thymi from kk-IL4 mice have decreased surface expression of class II MHC, the presumed physiologic surface ligand for CD4 within the thymus (57) .
An increasing body of evidence indicates that engagement of TCR-a/(3 on CD4+CD8+ thymocytes by self-MHC, presumably as part of a complex with self-antigen peptides, is critical both for the development of T cells with receptors capable of recognizing foreign antigen-self-MHC complexes (positive selection) as well as the deletion of T cells bearing TCR with potentially harmful self-reactivity (negative selection ; for review see reference 58) . The signals by which TCR engagement leads to either positive or negative selection of thymorytes remain poorly understood . In a model for negative selection using cultured fetal thymus lobes, CD4+CD8+ thymocytes which mobilize calcium after treatment with anti-CD3 or antiTCR-ot/,6 mAbs are also eliminated by these mAbs during organ culture (59) (60) (61) . This correlation between TCR-mediated calcium fluxes and in vitro deletion also provides a plausible explanation for the depletion of CD4+CD8+ thymocytes observed in all lines of lck-IL4 mice. Lck-IL4 CD4+CD8+ thymocytes, by virtue of their increased mobilization of [Ca 2 +] i after TCR-CD3 complex engagement, might also be more prone to intrathymic deletion than normal double-positive thymocytes.
The expression of IL-4 intrathymically exerted different effects on mature CD4+CD8 -as compared with CD4 -CD8+ Tlineage cells. Only CD4 -CD8+ thymocytes were increased in absolute numbers in these thymi, while, in contrast, only CD4' and not CD8+ T cells were found in the peripheral compartment . This suggests that CD4 -CD8+ thymocyte emigration was blocked in lck-IL4 mice, or that ifemigration occurred, these cells failed to proliferate at peripheral sites. A significant, but less severe, decrease in the emigration of CD4+CD8`thymorytes might also account for the reduced numbers of peripheral lck-IL4 CD4+ T cells we observed. Although the mechanisms involved in the emigration of single-positive thymorytes into the circulation are poorly understood, our results suggest that cytokines such as IL-4 can differentially regulate this process in CD4+CD8' and CD4 -CD8+ T lineage cells . The observation that IL-4 in vitro is significantly more effective in promoting the growth of CD4 -CD8+ compared with CD4+CD8' thymocytes (17) indicates that these two populations may differ intrinsically in their responses to IL-4 by other criteria as well.
Peripheral T cells as well as mature TCR-00-bearing single-positive thymorytes from lck-IL4 mice were markedly defective in their mobilization of calcium in response to anti-CD3 mAb or the mitogen, Con A (Fig. 6) . However, kk-11,4 T cells appeared to proliferate as well as control cells in response to anti-CD3 or anti-TCRa/(3 mAb (Fig. 7) . Although thymidine incorporation by lck-IL4 splenocytes was lower than that by splenocytes from littermate controls, this decrease was proportional to the lower percentage of peripheral T cells found in this transgenic population (see legend to Fig . 7) . The mechanism(s) responsible for this relatively selective defect in proximal signal transduction by mature lck-IL4 Tlineage cells remain to be defined. T cell proliferation after activation via the TCR-CD3 complex has previously been shown to be dependent on the interaction of IL2 with its specific high-affinity receptor (62) , suggesting that this interaction occurred normally in Ick-IL4 peripheral T cells. This interpretation is supported by the fact that 11,2 mRNA accumulation in lck-IL4 cells activated with either anti-CD3 mAb, Con A, or ionomycin and PMA was at least equal to that observed in littermate controls (data not shown) . Therefore, it is possible that lck-IL4 and peripheral T cells may be capable of IL2 production by a calcium-independent pathway. Since a calcium-independent pathway for IL2 production has previously only been described in murine T cell hybridoma line variants or mutants deficient in CD3-, q chains 9 7 Lewis et al . (63, 64) , it will be of interest to confirm that TCR-mediated proliferation of mature kk-IL4 Tlineage cells is calcium indent and, ifso, whether these cells have decreased CD3-,q expression as well as reduced activation-induced phosphoinsoitide hydrolysis . Alternatively, mature lck-IL 4 thymocytes and T cells may be more susceptible to inhibition of TCRmediated calcium mobilization by anti-CD4 or -CD8 mAb, which were used to identify cell subsets in these assays, than are control cells. Such inhibition of TCR-mediated calcium mobilization by anti-CD4 mAb has previously been observed in certain T cell clones (65) .
An unexpected finding in lck-IL4 mice was their susceptibility to severe infection by the pinworm Syphacia obvelata . Previous adoptive transfer studies with nude mice have indicated that Tlineage cells may be critical for the control of this pathogen (50) . In other murine models, CD4+ T cells have also been shown to be important for the control ofother parasitic infections, including Nippostrongylus and Leishmania (66, 67) . Therefore, it is possible that the generally low numbers of peripheral lck-IL4 T cells, as well as their apparent functional defects, could both contribute to the vulnerability of lck-IL4 mice to parasitic infection. It remains to be shown that kk-IL4 T cells have defective antigen-specific responses in vitro or in vivo.
While preparing this manuscript we became aware ofdata by Tepper et al. (68) showing that an IL4 transgene under the control ofthe u H chain enhancer results in the increased expression of 11,4 by -T-as well as B-lineage cells . These mice demonstrate most of the phenotypic alterations in Vintage cells we have observed in lck-IL4 mice, confirming that these results are attributable to the IL4 gene product itself. However p. H chain enhancer-IL4 transgenic mice differ from lck-11,4 mice in that their serum levels of IgG1 and IgE isotypes are increased, and their skin and eyes are infiltrated with large numbers ofmast cells. Our failure to observe these effects on nonTlineage cells in lck-11,4 mice, despite their constitutive intrathymic production ofsignificant amounts of IL-4, indicates that this cytokine acts locally rather than systemically, even when it is overexpressed in vivo. A soluble form of the IL4R has recently been identified in the circulation ofmice (69, 70) . Soluble IL4R could potentially bind excess 11,4 produced in tissues and prevent the occurrence of systemic effects . Recent studies by Maliszewski et al. (45) have shown that soluble IL4R can inhibit IL4-mediated effects in vitro. Our results suggest that mechanisms of this type, limiting the effects of IL4 at a distance, are of considerable importance. In the absence ofsuch regulation, peripheral IL4 production in response to inflammatory stimuli could potentially compromise intrathymic T cell development . Hence, it will be of interest to determine whether the levels of circulating IL4-IL4R complexes are increased in lck-IL4 mice, and whether the production of soluble receptor is upregulated in response to the constitutive synthesis of 11,4 intrathymically.
